SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Smart exercise planning could boost recovery for people with cancer

2.

Top FDA Official Exits; SCOTUS Takes Up Obamacare Case; Texas Doc Suspended

3.

PET-CT finds further-reaching metastases in patients with locally advanced breast cancer.

4.

Sub-Q Ketamine is Safe and Very Effective for Severe Depression.

5.

Big Gain in PFS With Metastasis-Directed RT for Oligometastatic Pancreatic Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot